Adarv Med AB
ActiveKey figures
Key figures
2025Summary: Adarv Med AB
What kind of company is it?
Adarv Med AB (org. no. 559110-7791) is a limited company (AB). The company was registered in 2017 and has existed for 9 years. Registered seat: Solna. Industry according to Statistics Sweden: other general medical practice activities (SNI 86212).
How is the company doing financially?
Net sales in financial year 2025 were 1 504 148 kr, up 7,0 % on the previous year (1 406 174 kr). From 2022 to 2025, net sales declined by an average of 16,1 % per year. Net profit for 2025 was 380 440 kr (25,3 % of net sales). The company was profitable in all 4 reported financial years. At the end of financial year 2025, total assets were 3 912 020 kr and equity 2 350 241 kr (equity ratio 60,1 %). The annual report for 2025 proposes a dividend of 300 000 kr.
Where does the data come from and how up to date is it?
Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by one person. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.
Dividend
from the annual reportProposed dividend 300 000 kr.
Summary of annual reports2022–2025
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Sales revenue | 2 545 143 | 1 886 362 | 1 406 174 | 1 504 148 |
| Profit for the reporting year | 480 851 | 400 786 | 305 719 | 380 440 |
| Retained earnings of previous periods | — | — | — | — |
| Total assets | 3 965 711 | 3 885 814 | 3 672 275 | 3 912 020 |
| Total liabilities | 1 752 414 | 1 621 731 | 1 452 474 | 1 561 779 |
| Total equity | 2 213 297 | 2 264 083 | 2 219 801 | 2 350 241 |
| Employees | — | — | — | — |
| Proposed dividend | — | 350 000 | 250 000 | 300 000 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.